← Leaderboards
Sandra E Juul
University Of Florida
$29,031,851
Attributed
$35,395,903
Total exposure
22
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,379,566 · 23
By mechanism
U01$23,395,419 · 2
R01$9,418,183 · 4
P50$4,983,663 · 1
P51$1,083,485 · 6
R21$932,810 · 2
M01$365,006 · 5
Top collaborators
- Yvonne W Wu5 shared
- M J Guralnick1 shared
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainInfantErythropoietinBrain InjuriesCerebral PalsyNeonateNeuroprotectionEvaluationInjurySafetyDoseAcuteSurvivorsAnimal ModelCessation Of LifeMagnetic Resonance ImagingNeonatalSeveritiesBiochemicalSiteNeurologicMonitorNeurodevelopmentNeurological Outcome
Grant awards (64)
Intellectual and Developmental Disabilities Research Center$1,168,116
P50 · FY2025 · HD · contact PI
Intellectual and Developmental Disabilities Research Center$1,271,849
P50 · FY2024 · HD · contact PI
Trial of Darbepoetin plus slow-release intravenous iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants$543,970
R01 · FY2024 · HD · contact PI
14th Hershey Developmental Brain Injury Conference$20,000
R13 · FY2024 · NS · contact PI
Intellectual and Developmental Disabilities Research Center$1,271,849
P50 · FY2023 · HD · contact PI
Trial of Darbepoetin plus slow-release intravenous iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants$563,813
R01 · FY2023 · HD · contact PI
Intellectual and Developmental Disabilities Research Center$1,271,849
P50 · FY2022 · HD
Trial of Darbepoetin plus slow-release intravenous iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants$492,337
R01 · FY2022 · HD · contact PI
13th Hershey Developmental Brain Injury Conference$25,000
R13 · FY2022 · NS · contact PI
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC$3,533,187
U01 · FY2020 · NS
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC$2,191,803
U01 · FY2019 · NS
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC$2,258,351
U01 · FY2018 · NS
Preterm Epa Neuroprotection Trial (PENUT Trial) CCC$235,700
U01 · FY2018 · NS · contact PI
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC$2,512,822
U01 · FY2017 · NS
Preterm Epo Neuroprotection Trial (PENUT Trial) CCC$849,853
U01 · FY2017 · NS · contact PI
Biomarkers of Neonatal Encephalopathy in a Nonhuman Primate Model$641,766
R01 · FY2017 · HD · contact PI
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC$2,231,942
U01 · FY2016 · NS
Preterm Epo Neuroprotection Trial (PENUT Trial) CCC$1,122,470
U01 · FY2016 · NS · contact PI
Biomarkers of Neonatal Encephalopathy in a Nonhuman Primate Model$642,734
R01 · FY2016 · HD · contact PI
A novel ferret model of preterm encephalopathy$193,125
R21 · FY2016 · NS · contact PI
Preterm Epo Neuroprotection Trial (PENUT Trial) CCC$1,939,477
U01 · FY2015 · NS · contact PI
Biomarkers of Neonatal Encephalopathy in a Nonhuman Primate Model$635,327
R01 · FY2015 · HD · contact PI
A novel ferret model of preterm encephalopathy$231,750
R21 · FY2015 · NS · contact PI
Preterm Epo Neuroprotection Trial (PENUT Trial) CCC$3,121,909
U01 · FY2014 · NS · contact PI
Preterm Epo Neuroprotection Trial (PENUT Trial) CCC$890,373
U01 · FY2014 · NS · contact PI
Biomarkers of Neonatal Encephalopathy in a Nonhuman Primate Model$640,177
R01 · FY2014 · HD · contact PI
Preterm Epo Neuroprotection Trial (PENUT Trial) CCC$236,227
U01 · FY2014 · NS · contact PI
Preterm Epo Neuroprotection Trial (PENUT Trial) CCC$98,400
U01 · FY2014 · NS · contact PI
Preterm Epo Neuroprotection Trial (PENUT Trial) CCC$2,172,905
U01 · FY2013 · NS · contact PI
Biomarkers of Neonatal Encephalopathy in a Nonhuman Primate Model$650,456
R01 · FY2013 · HD · contact PI
Optimizing Neuroprotection Following Perinatal Asphyxia$719,764
R01 · FY2011 · HD · contact PI
OPTIMIZING NEUROPROTECTION FOLLOWING PERINATAL ASPHYXIA$156,634
P51 · FY2011 · RR · contact PI
Optimizing Neuroprotection Following Perinatal Asphyxia$738,939
R01 · FY2010 · HD · contact PI
Epo Neuroprotection of ELBW Infants: Planning Grant$156,000
R34 · FY2010 · NS · contact PI
OPTIMIZING NEUROPROTECTION FOLLOWING PERINATAL ASPHYXIA$155,086
P51 · FY2010 · RR · contact PI
Optimizing Neuroprotection Following Perinatal Asphyxia$731,137
R01 · FY2009 · HD · contact PI
Optimizing Neuroprotection Following Perinatal Asphyxia$336,500
R01 · FY2009 · HD · contact PI
OPTIMIZING NEUROPROTECTION FOLLOWING NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY$315,187
P51 · FY2009 · RR · contact PI
Optimizing Neuroprotection Following Perinatal Asphyxia$711,460
R01 · FY2008 · HD · contact PI
Optimizing Neuroprotection Following Perinatal Asphyxia$706,395
R01 · FY2007 · HD · contact PI
SAFETY & EFFICACY OF R-ERYTHROPOIETIN AS A RESCUE AGENT$94,326
P51 · FY2006 · RR · contact PI
SAFETY AND EFFICACY OF RECOMBINANT ERYTHROPOIETIN (REPO) AS A RESCUE AGENT FOR A$80,468
P51 · FY2005 · RR
PHARMACOKINETICS OF ERYTHROPOIETIN IN THE CSF OF MACAQUES NEMESTRINA$80,468
P51 · FY2005 · RR
OPTIMIZING IRON STATUS IN THE PRETERM NEONATE$17,828
M01 · FY2005 · RR
Epo as a Rescue Agent for Perinatal Hypoxia-Ischemia$170,550
R21 · FY2004 · HD
Nonhematopoietic Developmental Functions of EPO$165,852
R01 · FY2004 · HD
PHARMACOKINETICS OF ERYTHROPOIETIN IN THE CSF OF MACAQUES NEMESTRINA$100,658
P51 · FY2004 · RR
SAFETY AND EFFICACY OF RECOMBINANT ERYTHROPOIETIN (REPO) AS A RESCUE AGENT FOR A$100,658
P51 · FY2004 · RR
Optimizing iron status in the preterm neonate$7,374
M01 · FY2004 · RR
Epo as a Rescue Agent for Perinatal Hypoxia-Ischemia$170,550
R21 · FY2003 · HD
Nonhematopoietic Developmental Functions of EPO$165,852
R01 · FY2003 · HD
Epo as a Rescue Agent for Perinatal Hypoxia-Ischemia$166,835
R21 · FY2002 · HD
Nonhematopoietic Developmental Functions of EPO$165,852
R01 · FY2002 · HD
IDIOPATHIC NEUTROPENIA IN NEONATES$207,281
M01 · FY2001 · RR
Nonhematopoietic Developmental Functions of EPO$165,852
R01 · FY2001 · HD
IDIOPATHIC NEUTROPENIA IN NEONATES$55,741
M01 · FY2001 · RR
EFFECT OF MENINGITIS INTRAVENTRICULAR HEMORRHAGE AND BIRTH ASPHYXIA$38,391
M01 · FY2000 · RR
IDIOPATHIC NEUTROPENIA IN NEONATES$38,391
M01 · FY2000 · RR
NONHEMATOPOIETIC DEVELOPMENT FUNCTION OF ERYTHROPOIETIN$0
M01 · FY2000 · RR
ERYTHROPOIETIN CONCENTRATION IN HUMAN MILK$0
M01 · FY2000 · RR
ERYTHROPOIETIN CONCENTRATION IN HUMAN MILK$0
M01 · FY2000 · RR
IDIOPATHIC NEUTROPENIA IN NEONATES$0
M01 · FY2000 · RR
EFFECT OF MENINGITIS INTRAVENTRICULAR HEMORRHAGE AND BIRTH ASPHYXIA$0
M01 · FY2000 · RR
NONHEMATOPOIETIC DEVELOPMENT FUNCTION OF ERYTHROPOIETIN$0
M01 · FY2000 · RR